Missouri HB 2641 Brings Hemp Cannabinoid Sales to Dispensaries
New law authorizes licensed cannabis retailers to sell hemp-derived products under state oversight for the first time.

Captivating evening view of the South Carolina State House with grand columns and soft lighting.
Dispensaries Gain Hemp Sales Authority Under New Framework
HB 2641 creates the first explicit pathway for Missouri's licensed cannabis retailers to sell hemp-derived cannabinoid products, including delta-8 THC, delta-10 THC, and THCA flower. Under prior law, dispensaries operating under Article XIV of the Missouri Constitution could only sell products derived from state-tracked cannabis. Hemp products—defined federally as containing ≤0.3% delta-9 THC by dry weight—remained in a legal gray zone. Gas stations and vape shops sold them with no state oversight.
The new statute amends Missouri Revised Statutes Chapter 195 to allow Department of Health and Senior Services-licensed facilities to stock hemp products alongside traditional cannabis inventory. Products must meet the federal 0.3% delta-9 threshold and carry third-party lab certificates of analysis showing total cannabinoid profiles, including THCA and other isomers.
Dispensaries must source hemp products only from processors registered with the Missouri Department of Agriculture's industrial hemp program. Direct-to-consumer hemp sales from unlicensed retailers remain unaffected by HB 2641, though enforcement agencies have signaled increased scrutiny of conversion processes that synthesize delta-8 from CBD isolate.
Consumer Purchase Limits and Data Tracking Requirements
HB 2641 imposes a combined purchase limit of 6 ounces per 30-day period across all cannabis and hemp products, tracked through the state's existing seed-to-sale system. Patients and adult-use customers will see hemp purchases counted against their monthly allotment—a departure from the unregulated hemp market where no purchase caps existed.
Key tracking mandates include:
- Real-time entry of hemp product sales into the DHSS Metrc-equivalent system within 24 hours of transaction
- Mandatory ID scanning for all purchasers, including those buying hemp products previously sold without age verification in many retail settings
- Quarterly reporting of total cannabinoid sales by product type, with delta-8 and THCA tracked separately from delta-9 cannabis
- Retention of purchase records for seven years, accessible to DHSS auditors and law enforcement with administrative subpoena
The data requirements mirror Colorado's 2023 hemp convergence model, which folded intoxicating hemp into the regulated cannabis framework after a spike in emergency-room visits linked to unregulated delta-8 edibles. Missouri's DHSS has 90 days from the January 1 effective date to publish final tracking protocols.
Decarboxylation Math and the THCA Loophole
The statute doesn't address total THC calculations. That leaves open the question of how THCA flower—which converts to delta-9 THC at roughly 87.7% efficiency when smoked—will be classified for purchase-limit purposes. THCA is non-intoxicating in raw form but decarboxylates into psychoactive delta-9 upon heating. A 3.5-gram eighth of 25% THCA flower yields approximately 767 mg of delta-9 THC after combustion, equivalent to a mid-potency edible dose for many users.
Federal hemp law measures only pre-decarboxylation delta-9 content, allowing THCA flower with <0.3% delta-9 to circulate as legal hemp. Missouri's HB 2641 adopts the same standard by reference to 7 U.S.C. § 1639o, meaning dispensaries can sell THCA flower under the hemp category even as it delivers delta-9 effects indistinguishable from regulated cannabis.
For context on Missouri's broader hemp policy landscape, see the CannIntel topic hub on Missouri Hemp Cannabinoid Regulation.
The Missouri Cannabis Trade Association issued a statement September 29 noting that "total THC" language—common in states like Minnesota and Oregon—was debated during HB 2641's markup but removed in committee. Enforcement will vary. Some dispensaries may voluntarily count THCA against the 6-ounce cap using conversion math; others will treat it as a separate hemp category until DHSS issues clarifying guidance.
Frequently asked questions
What hemp products can Missouri dispensaries sell under HB 2641?
Dispensaries can sell any hemp-derived cannabinoid product meeting the federal ≤0.3% delta-9 THC standard, including delta-8, delta-10, HHC, and THCA flower. Products must carry certificates of analysis from ISO-accredited labs and be sourced from state-registered hemp processors.
Does the 6-ounce purchase limit include hemp and cannabis together?
Yes. HB 2641 creates a combined 6-ounce per 30-day limit across all products sold by dispensaries, whether classified as cannabis or hemp. Purchases are tracked in real time through Missouri's seed-to-sale system, and dispensaries must deny sales that exceed the cap.
How is THCA flower treated under Missouri's hemp law?
THCA flower is classified as hemp if it contains ≤0.3% delta-9 THC by dry weight before decarboxylation. The statute doesn't require total THC calculations, leaving open whether THCA counts against purchase limits based on its post-combustion delta-9 content. DHSS guidance expected by March 2027.
Can gas stations and smoke shops still sell hemp products?
Yes. HB 2641 only regulates hemp sales within licensed dispensaries. Unlicensed retailers can continue selling hemp products under existing federal and state hemp laws, though they aren't subject to the purchase tracking or ID requirements that apply to dispensaries.
When does HB 2641 take effect?
January 1, 2027. Missouri DHSS has until March 31, 2027, to publish final rules on hemp product tracking, labeling standards, and total cannabinoid reporting requirements for dispensaries.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

No on 8 Campaign Releases First Ads Focused on Public Health
Opposition to California's Proposition 8 cannabis repeal launches television spots emphasizing regulated market safety and youth protection.

DEA and FDA Drug Scheduling Process Faces Accountability Criticism
Libertarian analysis argues federal drug-ban procedures lack transparency and consistent review standards.

Pennsylvania Advances Bill Allowing Medical Marijuana in Hospitals
Terminally ill patients could use medical cannabis in Pennsylvania hospitals under legislation advancing through the state legislature.
More from the newsroom

First National Study Counts 110,000 Medical Cannabis Caregivers
New research provides the first comprehensive estimate of designated caregivers dispensing medical cannabis to patients across U.S. state programs.

Heyliger-Marten Warns Parliament Cannabis Law Rejection Risks Native Nations
Sint Maarten's Prime Minister links parliamentary approval of pending cannabis legislation to financial obligations tied to the Native Nations entity.

Pennsylvania Democrats Tie Marijuana Legalization to Three Senate Races
State party frames adult-use cannabis as a November ballot issue in targeted districts where Republican incumbents hold narrow margins.